GO:0015741 fumarate transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015741 (fumarate transport) describes the directed movement of fumarate into, out of, or within a cell by transporters or pores.
• Fumarate transport is central to mitochondrial energy metabolism and can influence the electron transport chain when fumarate acts as a terminal electron acceptor.
• In Helicobacter pylori, fumarate transport has been characterized as a specific carrier-mediated process.
• Fumarate uptake in vascular smooth muscle supports metabolism of exogenous fumarate and 3-phosphoglycerate.
• Dysregulated fumarate transport and fumarate accumulation are linked to ischemia-reperfusion injury and mitochondrial ROS production.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of candidate fumarate transporters and their metabolic roles.
Description
Fumarate transport (GO:0015741) is the directed movement of fumarate into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Fumarate is a key intermediate of the tricarboxylic acid (TCA) cycle and also serves as a signaling molecule and, under some conditions, as a terminal electron acceptor in the mammalian electron transport chain. Because fumarate cannot freely diffuse across lipid bilayers at sufficient rates, dedicated transport systems are required to move it between cellular compartments and across the plasma membrane. Researchers study fumarate transport to understand mitochondrial bioenergetics, redox balance, and metabolic reprogramming in disease. In Helicobacter pylori, fumarate transport has been biochemically characterized, revealing carrier-mediated uptake that supports the pathogen's metabolism. In mammalian vascular smooth muscle, exogenous fumarate is transported and metabolized, linking transport to tissue energy supply. Ischemic accumulation of succinate, a related TCA intermediate, controls reperfusion injury through mitochondrial ROS, highlighting how dicarboxylate transport and metabolism shape disease outcomes. This article integrates the QuickGO definition of GO:0015741 with verified PubMed literature to outline the mechanism, key genes, disease relevance, and experimental models for studying fumarate transport.
fumarate transport At A Glance
| GO ID | GO:0015741 |
|---|---|
| GO term | fumarate transport |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Directed movement of fumarate across membranes via transporters or pores |
| Biological context | TCA cycle intermediate transport, mitochondrial metabolism, and redox homeostasis |
| Example organism | Helicobacter pylori fumarate transport has been biochemically characterized |
| Disease link | Ischemia-reperfusion injury via succinate/fumarate-related mitochondrial ROS |
| Research methods | Transport assays, CRISPR knockout/knock-in, metabolomics, and proteomics |
What Is GO:0015741?
GO:0015741 (fumarate transport) is defined by QuickGO as the directed movement of fumarate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. In practice, this includes plasma membrane uptake and efflux, mitochondrial import and export, and any carrier- or channel-mediated translocation of the fumarate dianion across biological membranes.
Why Is fumarate transport Important in Cell Biology?
Fumarate transport is important because fumarate sits at the intersection of energy metabolism, mitochondrial redox biology, and cell signaling. When fumarate accumulates or is mislocalized, it can alter the electron transport chain, contribute to mitochondrial ROS production, and modify proteins through succination. Understanding how fumarate enters and exits compartments is therefore essential for interpreting metabolic phenotypes in cancer, ischemia, and infection.
• Fumarate can act as a terminal electron acceptor in the mammalian electron transport chain, making its transport relevant to mitochondrial respiration.
• Ischemic accumulation of succinate, a related dicarboxylate, controls reperfusion injury through mitochondrial ROS, implicating dicarboxylate transport in ischemia-reperfusion damage.
• SLC26 anion transporters can mediate transport of dicarboxylates including fumarate, linking a large gene family to fumarate transport.
• Helicobacter pylori possesses a characterized fumarate transport system that supports its unique metabolism.
• Fumarate transport in vascular smooth muscle supports metabolism of exogenous fumarate and 3-phosphoglycerate.
• Fumarate accumulation can drive succination of proteins, a post-translational modification relevant to metabolic disease.
• Fumarate reductase enzymes interconvert fumarate and succinate, coupling transport to anaerobic metabolism.
• CRISPR-based models allow causal testing of candidate fumarate transporters in disease contexts.
What Happens During fumarate transport?
Substrate recognition and binding at the transporter
In simple terms: A transporter protein recognizes fumarate and grabs it.
Fumarate transport begins when a membrane protein binds the fumarate dianion with sufficient affinity and specificity. In Helicobacter pylori, fumarate transport has been characterized as a saturable, carrier-mediated process, indicating a proteinaceous transporter rather than simple diffusion. SLC26 anion transporters are known to handle a range of anions and can contribute to dicarboxylate transport, providing a structural framework for fumarate recognition.
Translocation across the membrane
In simple terms: The transporter moves fumarate from one side of the membrane to the other.
After binding, the transporter undergoes conformational changes that expose fumarate to the opposite side of the membrane. This step is energy-dependent or gradient-driven depending on the transporter family. In vascular smooth muscle, exogenous fumarate is transported into cells and subsequently metabolized, demonstrating functional translocation across the plasma membrane. The direction of movement (influx vs efflux) depends on the transporter and cellular context.
Mitochondrial fumarate handling
In simple terms: Inside the cell, fumarate often moves into mitochondria for energy reactions.
Once inside the cell, fumarate can be transported into mitochondria, where it participates in the TCA cycle and can influence the electron transport chain. Fumarate has been shown to act as a terminal electron acceptor in the mammalian electron transport chain under specific conditions, linking mitochondrial fumarate availability to respiration. Mitochondrial dicarboxylate carriers and related transporters facilitate this compartmental movement.
Metabolic conversion and downstream effects
In simple terms: After transport, fumarate is converted to other molecules or modifies proteins.
Transported fumarate can be converted to malate or succinate, depending on the enzyme context. Fumarate reductase catalyzes the reduction of fumarate to succinate in anaerobic metabolism. In mammalian systems, fumarate can also non-enzymatically modify cysteine residues, a process called succination, which is detected in the succinated proteome. These downstream reactions connect fumarate transport to broader metabolic and signaling networks.
Integration with redox and ROS biology
In simple terms: Fumarate transport affects how cells handle oxidative stress.
Fumarate transport influences mitochondrial redox state. Ischemic accumulation of succinate, a closely related dicarboxylate, drives mitochondrial ROS production upon reperfusion, and fumarate is interconverted with succinate in the TCA cycle. Thus, transport of fumarate and succinate across membranes can modulate reperfusion injury and redox signaling. This makes fumarate transport a potential target for modulating oxidative damage in ischemia.
Key Genes Involved in GO:0015741 fumarate transport
The following genes and proteins have been experimentally linked to fumarate transport or its metabolic context, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC26A1 | Anion transporter capable of dicarboxylate transport | Candidate for fumarate transport; SLC26 family review |
| SLC26A2 | Anion transporter with broad substrate range | Potential fumarate transport; SLC26 family review |
| SLC26A3 | Anion exchanger | May transport dicarboxylates; SLC26 family review |
| SLC26A4 | Anion transporter | Potential fumarate transport; SLC26 family review |
| SLC26A5 | Anion transporter | Potential fumarate transport; SLC26 family review |
| SLC26A6 | Anion exchanger | May transport dicarboxylates; SLC26 family review |
| SLC26A7 | Anion transporter | Potential fumarate transport; SLC26 family review |
| SLC26A8 | Anion transporter | Potential fumarate transport; SLC26 family review |
| SLC26A9 | Anion transporter | Potential fumarate transport; SLC26 family review |
| SLC26A10 | Anion transporter | Potential fumarate transport; SLC26 family review |
| SLC26A11 | Anion transporter | Potential fumarate transport; SLC26 family review |
| FRD1 | Fumarate reductase subunit | Catalyzes fumarate reduction to succinate |
| FRD2 | Fumarate reductase subunit | Catalyzes fumarate reduction to succinate |
| SDHA | Succinate dehydrogenase subunit A | TCA cycle enzyme interconverting succinate and fumarate |
| SDHB | Succinate dehydrogenase subunit B | TCA cycle enzyme interconverting succinate and fumarate |
| SDHC | Succinate dehydrogenase subunit C | TCA cycle enzyme interconverting succinate and fumarate |
| SDHD | Succinate dehydrogenase subunit D | TCA cycle enzyme interconverting succinate and fumarate |
How Is fumarate transport Regulated?
Fumarate transport is regulated at multiple levels. Transporter expression levels and post-translational modifications can alter transport capacity. Substrate availability and metabolic demand influence flux through fumarate transport pathways, as seen in vascular smooth muscle where exogenous fumarate is metabolized. In ischemia, accumulation of succinate and fumarate-related metabolites is controlled by mitochondrial redox state and reperfusion, which indirectly regulates transport needs. Fumarate itself can modify proteins via succination, potentially affecting transporter function.
fumarate transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC26A6 | Ischemia-reperfusion injury | Knockout mouse with renal ischemia-reperfusion |
| SDHA | Cancer metabolism | Knockout cancer cell line with metabolomics |
| FRD1 | Helicobacter pylori infection | Knockout H. pylori strain with transport assay |
| SLC26A3 | Vascular smooth muscle metabolism | Overexpression in smooth muscle cells |
| SLC26A11 | Protein succination | Point mutation at transport residue with proteomics |
Ischemia-reperfusion injury
Ischemic accumulation of succinate controls reperfusion injury through mitochondrial ROS, and fumarate is metabolically interconverted with succinate. Fumarate transport may therefore influence the size of the succinate pool and the extent of ROS production upon reperfusion. Targeting fumarate transport could modulate ischemic damage in heart, kidney, and brain.
Cancer metabolism
Fumarate can act as a terminal electron acceptor in the mammalian electron transport chain, supporting mitochondrial function under stress. In cancer, metabolic reprogramming may alter fumarate transport to sustain energy production and redox balance. Succination of proteins by fumarate could also contribute to oncogenic signaling.
Helicobacter pylori infection
Helicobacter pylori possesses a characterized fumarate transport system that supports its metabolism in the gastric environment. Understanding this transport could inform strategies to inhibit the pathogen. The transporter may be a target for antimicrobial development.
Vascular smooth muscle metabolism
Transport and metabolism of exogenous fumarate in vascular smooth muscle links fumarate uptake to tissue energy supply. Dysregulation of this process could contribute to vascular dysfunction. This provides a model for studying fumarate transport in non-mitochondrial compartments.
From fumarate transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for fumarate transport? | CRISPR knockout cell line |
| Does a specific residue mediate fumarate binding? | Point mutation knock-in |
| Can a transporter be tagged for localization? | Tagged knock-in |
| Does overexpression increase fumarate uptake? | Overexpression cell model |
| Which genes regulate fumarate transport? | CRISPR library screening |
| How does fumarate transport affect metabolism? | Metabolomics and proteomics |
How to Study the fumarate transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled fumarate uptake | Transport rate and kinetics | Characterizing transporters |
| Metabolomics | Fumarate and TCA intermediate levels | Metabolic flux analysis |
| Succinated proteome profiling | Protein succination | Post-translational modification studies |
| CRISPR knockout | Gene requirement for transport | Causal gene testing |
| CRISPR library screening | Genome-wide transport regulators | Unbiased discovery |
| RNA-seq | Transporter expression changes | Regulation studies |
| Proteomics | Transporter protein abundance | Expression validation |
| Imaging | Subcellular localization | Compartment-specific transport |
Transport assays
Radiolabeled or fluorescent fumarate uptake assays measure transport activity in cells or vesicles. In Helicobacter pylori, fumarate transport was characterized using such assays. These methods can determine Km, Vmax, and substrate specificity.
Metabolomics
Mass spectrometry-based metabolomics quantifies fumarate and related TCA intermediates. This approach has been used to study fumarate as a terminal electron acceptor. It can reveal how transport perturbations alter metabolic flux.
Proteomics and succination analysis
The succinated proteome can be mapped by mass spectrometry to identify proteins modified by fumarate. This links fumarate transport to post-translational modifications. It is useful for understanding downstream effects of fumarate accumulation.
CRISPR screening
Genome-wide CRISPR screens can identify genes required for fumarate transport or tolerance. SLC26 transporters are candidate genes for such screens. This approach enables unbiased discovery of transport regulators.
How CRISPR Can Be Used to Study GO:0015741 fumarate transport
Knockout
CRISPR knockout of candidate fumarate transporters such as SLC26 family members can test whether they are required for fumarate uptake or efflux. Knockout cells can be analyzed by transport assays and metabolomics. This provides causal evidence for gene function.
Point Mutation
Point mutations can be introduced into transporter genes to test specific residues predicted to bind fumarate. Such models help distinguish transport from other functions. They are useful for structure-function studies.
Knock-in
Knock-in of tagged transporters allows visualization and purification of the transport protein. This can reveal subcellular localization and interaction partners. It is valuable for studying compartment-specific fumarate transport.
Overexpression
Overexpression of candidate transporters can increase fumarate transport capacity and amplify phenotypes. This is useful for gain-of-function studies and for producing sufficient material for biochemical assays. It can also reveal toxicity from excess fumarate accumulation.
How EDITGENE Supports fumarate transport Research
Researchers studying fumarate transport-related genes often need to determine whether a candidate gene is causally involved in fumarate movement, metabolism, or disease. EDITGENE provides CRISPR-based cell models and screening services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for fumarate transport research.
Frequently Asked Questions About fumarate transport
What is fumarate transport?
Fumarate transport (GO:0015741) is the directed movement of fumarate into, out of, or within a cell by transporters or pores.
What genes are involved in fumarate transport?
SLC26 anion transporters are candidates, and fumarate reductase genes are involved in fumarate metabolism.
How is fumarate transported across membranes?
It is transported by carrier proteins such as SLC26 family members, often in a saturable manner.
Why is fumarate transport important in cancer?
Fumarate can act as a terminal electron acceptor and modify proteins, affecting cancer metabolism.
What diseases are linked to fumarate transport?
Ischemia-reperfusion injury and Helicobacter pylori infection are linked to fumarate transport and metabolism.
How can I study fumarate transport with CRISPR?
Use knockout, knock-in, or overexpression models to test candidate transporters.
What methods measure fumarate transport?
Radiolabeled uptake assays, metabolomics, and proteomics are commonly used.
Is fumarate transport related to succinate?
Yes, fumarate and succinate are interconverted in the TCA cycle and both are dicarboxylates.
What is the GO ID for fumarate transport?
The GO ID is GO:0015741.
Can fumarate transport be targeted therapeutically?
Modulating fumarate transport may influence ischemia-reperfusion injury and metabolic diseases.
Conclusion
Fumarate transport (GO:0015741) is a fundamental biological process that moves fumarate across cellular membranes via transporters or pores. It connects mitochondrial metabolism, redox biology, and disease, with roles in ischemia-reperfusion injury, cancer metabolism, and infection. CRISPR-based models and advanced omics methods now enable precise interrogation of the genes and mechanisms underlying fumarate transport.
References
- 1. Spinelli JB et al.. 2021. Fumarate is a terminal electron acceptor in the mammalian electron transport chain.. Science 374(6572):1227-1237 PMID: 34855504
- 2. Chouchani ET et al.. 2014. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.. Nature 515(7527):431-435 PMID: 25383517
- 3. Geertsma ER et al.. 2024. SLC26 Anion Transporters.. Handb Exp Pharmacol 283:319-360 PMID: 37947907
- 4. Mendz GL et al.. 1998. Characterization of fumarate transport in Helicobacter pylori.. J Membr Biol 165(1):65-76 PMID: 9705983
- 5. Merkley ED et al.. 2014. The succinated proteome.. Mass Spectrom Rev 33(2):98-109 PMID: 24115015
- 6. Reid GA et al.. 2000. Catalysis in fumarate reductase.. Biochim Biophys Acta 1459(2-3):310-5 PMID: 11004445
- 7. Finder DR et al.. 1999. Transport and metabolism of exogenous fumarate and 3-phosphoglycerate in vascular smooth muscle.. Mol Cell Biochem 195(1-2):113-21 PMID: 10395075
